The allowance of a patent typically signifies that the company has a new, protectable technology or method, which can lead to competitive advantages. For MyMD Pharmaceuticals, this could result in increased investor confidence and potential future revenue streams from the patented treatment method. The news is directly related to the company and is likely to be viewed positively by investors, hence the positive score. The importance is high as patents are critical in the pharmaceutical industry for protecting R&D investments and securing market exclusivity. The confidence level is high due to the direct mention of the patent allowance and its implications for the company's intellectual property portfolio.